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Introduction 
 
Two years ago the Supreme Court gave a broad ruling in favor of Pom 
Wonderful (hereafter “Pom”) in its Lanham Act suit claiming Coke’s Minute 
Maid unit’s labeling was deceptive. Coke labeled a product  
“POMEGRANATE BLUEBERRY” with “100% JUICE” strategically placed 
in large font right next to the name. In much smaller print was an 
explanation that the product was a “flavored blend of five fruit juices.” In 
actual fact the product contained three drops from an eyedropper of 
pomegranate juice and even less blueberry juice. As prices fluctuated the 
formula changed slightly. Its current version is a fairly even mix of apple 
and white grape juice (The Oyez Project 2014), but at the time of the suit it 
was 99.4% apple juice because huge amounts of concentrated apple juice 
were coming to the U.S. so cheaply that China was hit with anti-dumping 
duties (Bobelian 2014). 
Pom Wonderful LLC (hereafter Pom) felt that it created the market 
for pomegranate juice and argued that Coke’s Minute Maid unit’s “false and 
misleading labeling” harmed it’s market position and sales. Pom chose to 
challenge Coke under section 43a of the 1946 Lanham Act, a federal statute 
that protects businesses damaged by false advertising, false product 
descriptions and false representations about the nature of a product or 
service. The crux of Coke’s argument was that its label met the FDA 
requirements and therefore it should be exempt from Lanham Act suits.  
The oft overturned Ninth Circuit Court of Appeals [that year (the 
October 13th term) its decisions were unanimously overturned 100% of the 
time] found for Coke and issued an opinion offering broad exemptions from 
Lanham Act suits for products covered by more specific federal statutes like 
the FDCA (the FDA’s enabling legislation).  
Surprising no one, the Supreme Court decision overturned the 9th 
circuit and remanded the case for trial on its merits. What was surprising 
was the broad reach of the ruling. Businesses can now sue under the 
Lanham Act for false labeling, marketing and advertising even when those 
labels and statements do not violate FDA, FCC or other agency guidelines. 
The ruling met with approbation by such high profile journalists as Nina 
Totenberg and David Savage (Totenberg 2014; Savage 2014) and such 
veteran court watchers as Scotusblog’s John Duffy (Duffy 2014) and Ronald 
Mann (Mann 2014). These and others thought that more Lanham Act suits 
would stigmatize bad actors and punish them financially with consumers 
as the indirect beneficiary.  
In the next section we review new cases brought in the wake of the 
Supreme Court ruling. Then, we examine the consequences of the decision 
in terms of marketing and legal strategy. Finally, the teaching 
consequences of a more robust Lanham Act for the marketing professoriate 
are assessed.  
 
New Cases 
 
The court’s basic decision, if not the wide reach, was foreshadowed in oral 
arguments. Justice Kennedy said, “This is a label that cheats the public.” 
Alito, Kagan, Sotomayor, Roberts and Ginsburg all made comments or 
asked questions of the FDA’s Melissa Sherry or Coke’s Kathleen Sullivan 
that were skeptical of Coke and the FDA’s arguments.   
Subsequently, the courts have seen a rash of new cases, beefed up 
regulatory enforcements and new clarifications from the supreme court and 
lower courts, some for very familiar household products and businesses like 
Clorox vs. OxiClean [228 F.3d 24, 33 n.6], Dannon and then General Mills 
vs. Chobani [No. 16 CV 30, 2016 WL 369364 (N.D.N.Y. Jan. 29, 2016)]; Gen. 
Mills, Inc. v. Chobani, LLC, [No. 16 CV 58, 2016 WL 356039 (N.D.N.Y. Jan. 
29, 2016)], and Reed Construction Data Inc. vs McGraw Hill [Reed Constr. 
Data Inc. v. McGraw-Hill Cos., [49 F. Supp. 3d 385 (S.D.N.Y. 2014), aff'd --
- F. App'x ---, 2016 WL 80577 (2d Cir. Jan. 7, 2016)]. In the yogurt wars its 
competitors won an injunction against Chobani. The court decision said 
Chobani’s claims were literally false rather than allowable puffery. Church 
and Dwight’s OxiClean was told to discontinue advertising claims in it’s 
“Scary Bleach” commercial that Clorox’s chlorine bleach was “scary” or 
“worrying.” Defendant McGraw Hill though, won summary judgment 
(affirmed by the 3rd Circuit) based on “lack of materiality. 
Another case, followed closely in legal circles, but involving less well 
know companies, was Eastman Chen. Co. v. Plastipure, Inc. [775 F.3d 230 
(5th Cir. 2014)].  
Eastman felt its Tritan product was unfairly disparaged in Plastipure’s 
marketing materials. Plastipure argued that its evidence was based on a 
peer reviewed scientific paper, though Tritan was never mentioned in that 
paper (Ginsberg, Litman and Kevlin 2015). A jury trial which had found 
Plastipure and another firm Certichem, Inc. had made false statements of 
fact about Eastman’s Tritan product was appealed by Plastipure on the 
grounds that its marketing materials had spoken of scientific opinions 
rather than actual facts. The 5th Circuit federal court held that companies 
could not use scientific discourse to make marketing materials with claims 
that are factually false. The trial court’s decision was upheld.  
 
Ramifications for Marketing Strategy 
 
A broad decision allowing Lanham Act claims even when other, more 
primary government regulators permit something has the potential to 
create a tremendous upheaval in many product domains. Brands like 
Chobani that have built a certain cachet around being supposedly healthier 
will have to be more careful about the veracity of their marketing claims. 
Early Lanham Act victories are concentrated around comparative 
advertising claims, which have always been held under stricter review 
standards anyway.    
Product domains and industries like health and herbal supplements, 
organic foods and fitness supplements that have always been rife with fraud 
might be completely transformed by the Supreme Court’s ruling. The 
California Supreme court ruled against a firm that made demonstrably 
false claims that its products were “organic” even when lower courts argued 
for an exemption because Herb Thyme Farms did not violate still nascent 
federal laws or regulations (Quesada v Herb Thyme Farms, Inc).   Several 
suits against MusclePharm Corporation and its founder Bradley Pyatt 
might serve notice to an industry where the truth has often taken a back 
seat to profit. In the health supplement area, one ongoing suit alleges 
MusclePharm’s Arnold Schwarzenegger line of iron Mass weight gain 
products uses a label that has specific false claims about protein levels and 
other things (PricePlow 2016). This follows on the heals of a successful 
Lanham Act suit by a Georgia based competitor that claim competitive 
damage due to factually false claims about the amount of whey protein in 
some of its products (Hi-Tech Pharmaceuticals v MusclePharm Corp. 2016).  
Thus, we may see an era where a completely new class of marketing 
professionals who analyze competitors’ marketing claims looking for clearly 
deceptive or false statements. You may see new companies who offer strict 
chain of custody testing of ingredient and benefit claims. Assaying 
competitors’ products could become “de rigueur” in certain product domains. 
 
Teaching Ramifications for the Marketing Professoriate 
 
The feeling among both the journalistic literati and the legal experts 
was that the Supreme Court’s POM v Coke Ruling would benefit consumers 
(Totenberg 2014; Savage 2014; Duffy 2014; Mann 2014). Supplementing the 
lax oversight of regulatory agencies with competitive damage litigation 
would rein in some of the more egregious ethical (if not legal) violations. We 
could see Lanham Act suits over whether wild blueberries are really wild; 
fish is really fresh (can it be fresh if it was once frozen); spring water is 
really from a spring and natural is really natural.  
The herbal supplements industry represents a good teaching 
example. A study by Newmaster et al. (2013) found only 48% of the products 
tested even contained the product on the label and many of those contain 
fillers or contaminants, some of which pose serious health concerns. Only 
two of twelve company’s products contained what they said they did. 
Similar results for commercial seafood and black cohosh and other 
supplements were cited by O’Connor’s (2013) review of research in this area. 
So, it is easy to see the benefit to consumers from Lanham Act suits that 
root out just the most egregious fraudsters. Certainly post-menopausal 
women who took what they thought was black cohosh for hot flashes and 
perceived no health improvement—perhaps because they bought one of the 
25% of brands that contained an unrelated Chinese herbal plant (O’Connor 
2013) —would benefit. People deceived into drinking apple juice when they 
needed acai berry, blueberry or pomgranate for some health benefit would 
also benefit. And those people who paid extra for any special product from 
spring water which isn’t spring water to free range eggs from caged chickens 
to all beef hot dogs containing a substantial amount of pork would certainly 
benefit. 
In teaching the ramifications to students, however, professors should 
point out the effect that false claims, faked products and other Lanham Act 
torts have on honest competitors. Elements of the professoriate who use the 
Socratic Method might begin by asking students, “Who benefits from a 
broadly applicable Lanham Act?” Students will immediately see that 
consumers benefit from more honest labels and understand the effect on 
menopausal women who bought powdered rice and weeds labeled as Black 
Cohosh or people who bought ground up bitter weed, itself linked to rashes, 
nausea and flatulence, instead of the Echinacea they thought they were 
getting (O’Connor 2013). Through the Socratic process students could be 
drawn to understand the more direct beneficiary would be those two herbal 
remedy companies out of twelve that actually put what they say they do in 
their products, the companies which actually get their spring water from a 
spring, the companies which market wild blueberries that are really wild 
blueberries and companies like Pom Wonderful that make a pomegranate 
juice product which is actually made with pomegranate juice. 
 
Teaching Implications for Marketing Strategy, Marketing Research, 
Retailing 
 
Marketing strategy professors might also discuss the strategy implications. 
It may become routine marketing strategy, for example, to assay 
competitors’ products and assess the honesty of their labels and advertising 
claims. Marketing research professors may have students design testing 
and chain of custody procedures for the testing of fake products that would 
hold up in court. Retailing professors might talk about honestly pricing 
retailers (assuming these actually exist) challenging competitors’ high-low 
pricing scams (see Bhasin 2014).  
 
Implications for Teaching Marketing Ethics 
 
Marketing professors in a variety of classes might discuss the ethics issues 
related to POM vs. Coke and ask students. “What does Coke’s fight-to-the-
death/all-the-way-to-the-supreme-court strategy imply?” Was the ability to 
put similarly deceptive labels on its myriad of brands across numerous 
product categories so important that it compensated for the negative 
publicity associated with the case? After all a Justice of the Supreme Court 
(Kennedy) of the land would say out loud, “This is a label that cheats the 
public.” Another justice (Kagan) seemed visibly surprised to hear Coke’s 
counsel say that the label was still being used. Marketing ethics courses (or 
ethics modules within a different course) might also benefit from a 
discussion or case about how companies might set up internal review 
procedures and systems to assay their own products and take a closer look 
at their own labeling and advertising ethics.  
Finally, marketing professors might discuss what the ruling says 
about the federal regulatory agencies. What do students think about the 
FDA’s decision to allow labels like this in the first place or the lax "organic” 
standards? What does that tell us about the way regulatory agencies and 
by extension the government itself works? How many of the people involved 
in a rule making process that made it okay to label a product with three eye 
drops pomegranate and two of blueberry juice “POMGRANITE 
BLUEBERRY” with “100 JUICE” right below it went on to executive or 
consultancy positions in the companies they had recently regulated?  
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